Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC Saxagliptin 361442-04-8 100mg
SDP

Supplier:  Apexbio Technology LLC A8650100

Encompass_Preferred

Saxagliptin (CAS 361442-04-8) is a small molecule developed for the management of respiratory disorders including asthma and Chronic Obstructive Pulmonary Disease It exerts its pharmacological activity by selectively inhibiting phosphodiesterase-4 (PDE4) an enzyme involved in the degradation of cyclic AMP within inflammatory cells Inhibition of PDE4 is associated with anti-inflammatory effects reducing the release of pro-inflammatory mediators implicated in airway diseases Saxagliptin is orally bioavailable and is utilized in research focused on elucidating PDE4-mediated pathways in respiratory inflammation and evaluating new therapeutic strategies for asthma and COPD

Catalog No. 50-000-93006


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.